TYRATyra Biosciences, Inc.
$20.45+38% 1Y
$20.45
$13.9952 weeks$39.61
The financials
Tyra Biosciences, Inc. by the numbers
The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$49M | −$31M | n/a |
| Net income | −$46M | −$28M | n/a |
| Diluted EPS | −$0.69 | −$0.47 | n/a |
On our screens:Most shorted stocks